Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'

Valor-Méndez L, Tascilar K, Simon D, Distler J, Kleyer A, Schett G, Rech J (2021)

Publication Type: Journal article, Letter

Publication year: 2021

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

DOI: 10.1136/annrheumdis-2021-220898

Authors with CRIS profile

Koray Tascilar Department of Medicine 3 – Rheumatology and Immunology David Simon Department of Medicine 3 – Rheumatology and Immunology Jörg Distler Professur für Molekulare Mechanismen der Organfibrose Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

How to cite

APA:

Valor-Méndez, L., Tascilar, K., Simon, D., Distler, J., Kleyer, A., Schett, G., & Rech, J. (2021). Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2021-220898

MLA:

Valor-Méndez, Larissa, et al. "Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'." Annals of the Rheumatic Diseases (2021).

BibTeX: Download